HomeNewscoronavirusMaharashtra sees 1,832 COVID-19 cases, 2 deaths; active tally now 11,641

Maharashtra sees 1,832 COVID-19 cases, 2 deaths; active tally now 11,641

Coronavirus figures of Maharashtra are as follows: Positive cases 80,84,383; fresh cases 1832; death toll 1,48,195; recoveries 79,24,547; active cases 11,641; total tests 8,38,38,036.

August 21, 2022 / 22:11 IST
Story continues below Advertisement
Representative image (REUTERS/Danish Siddiqui)
Representative image (REUTERS/Danish Siddiqui)

Maharashtra on Sunday reported 1,832 COVID-19 cases and two fatalities, which took the tally to 80,84,383 and the toll to 1,48,195, a health department official said. A day earlier, the state had reported 1,855 cases and two deaths.

Of the new cases, Mumbai Circle led with 1,259, followed by Pune Circle (295), Nashik Circle (78), Nagpur Circle (100), Kolhapur Circle (39), Latur Circle (32), Aurangabad Circle (16), and Akola Circle (13). One of the two COVID-19 fatalities was reported from Mumbai city and the other from Satara in western Maharashtra, the official said.

Story continues below Advertisement

The recovery count increased by 2,055 in the past 24 hours and touched 79,24,547, leaving Maharashtra with an active caseload of 11,641. Mumbai accounts for 5,761 active cases, followed by 1,925 in Thane and 1,579 in Pune, he said.

The overall number of coronavirus tests in Maharashtra reached 8,38,38,036 after 30,421 samples were examined in the last 24 hours, he added. As per the state health department data, the recovery rate is 98.02 percent and the fatality rate stands at 1.83 percent.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show